Is a 5 mg once‑daily dose of amlodipine an appropriate starting dose for a 70‑year‑old female?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amlodipine 5mg as Starting Dose for 70-Year-Old Female

Yes, amlodipine 5 mg once daily is an acceptable and appropriate starting dose for a 70-year-old female with hypertension. However, if she is frail, has hepatic insufficiency, or is particularly small in stature, consider starting with 2.5 mg once daily instead.

Guideline-Based Recommendations

The 2020 International Society of Hypertension guidelines recommend calcium channel blockers (specifically dihydropyridine CCBs like amlodipine) as first-line therapy for patients over 55 years of age 1. The 2024 ESC guidelines similarly endorse dihydropyridine CCBs as one of the four major first-line antihypertensive drug classes with proven cardiovascular event reduction 2.

FDA-Approved Dosing

The FDA drug label explicitly states that the usual initial antihypertensive dose is 5 mg once daily 3. For elderly patients specifically, the label notes that "small, fragile, or elderly patients...may be started on 2.5 mg once daily" 3. This provides flexibility based on individual patient characteristics rather than age alone.

Age-Related Pharmacokinetic Considerations

Elderly patients demonstrate decreased clearance of amlodipine, resulting in approximately 40-60% higher drug exposure (AUC) 3. Research confirms elimination half-life is prolonged in elderly patients (64 ± 20 hours vs. 48 ± 8 hours in younger patients) 4. Despite these pharmacokinetic differences, clinical studies show that elderly patients actually achieve greater blood pressure reductions with similar doses compared to younger patients 4, 5.

Clinical Efficacy in Elderly Patients

A large open-label study of 5,135 patients demonstrated that amlodipine achieved blood pressure reductions of 25/16 mmHg in patients ≥65 years and 26/17 mmHg in those ≥75 years, with treatment success rates of 84.2% and 84.5% respectively 5. The adverse event profile was comparable across age groups (22.3% in ≥65 years vs. 18.0% in <65 years) 5.

Practical Dosing Algorithm

For a typical 70-year-old female:

  • Start with 5 mg once daily if she is robust and has normal liver function
  • Monitor blood pressure after 7-14 days
  • If blood pressure remains uncontrolled, titrate to 10 mg once daily 3
  • Approximately 45% of patients require uptitration to 10 mg for adequate control 6

Consider starting with 2.5 mg once daily if:

  • She is frail or has moderate-to-severe frailty 2
  • She has hepatic insufficiency 3
  • She is particularly small or fragile in stature 3
  • She has symptomatic orthostatic hypotension 2

Safety Considerations

The most common adverse effects in elderly patients are peripheral edema, headache, and dizziness 7, 5. These are generally mild to moderate and well-tolerated. The once-daily dosing improves adherence, which is particularly important in elderly patients 1.

Common Pitfalls to Avoid

  • Don't automatically reduce the dose solely based on age 70 - the standard 5 mg starting dose is appropriate unless specific risk factors are present
  • Don't combine with immediate-release nifedipine - this formulation should be avoided in hypertension management 7
  • Don't wait too long to uptitrate - if blood pressure remains elevated after 2-4 weeks on 5 mg, increase to 10 mg rather than adding additional agents prematurely 3
  • Monitor for ankle edema - this is the most common dose-limiting side effect, occurring in approximately 10% of patients 5

The 2025 AHA/ACC guidelines note that in pregnancy-capable individuals, extended-release nifedipine is preferred over amlodipine due to more robust safety data 8, but this consideration does not apply to a 70-year-old female.

Related Questions

With a blood pressure of 150/90 mmHg, should I continue amlodipine (AmLong) 2.5 mg in this patient?
What is the recommended starting dose and titration of amlodipine for adults with hypertension or chronic stable angina, and how should dosing be adjusted in patients over 65, with hepatic impairment, or low baseline blood pressure?
What are the indications, dosing regimen, contraindications, and common adverse effects of amlodipine?
Is headache a side effect of amlodipine and how should it be managed if it occurs?
Can the amlodipine dose be increased from 5 mg to 10 mg daily in a patient whose blood pressure is 180/96 mm Hg after 5 days of therapy?
If the patient's hook sign shows an intact tendon, is the test considered negative or positive?
What are the contraindications to adding escitalopram (Lexapro) 5 mg to vilazodone (Viibryd) 40 mg?
Is Neupogen (filgrastim) effective for HIV‑associated neutropenia?
In a 48-year-old woman presenting to the emergency department with acute dizziness, headache, and vertigo after a Valsalva maneuver, normal neurologic exam and no spontaneous nystagmus, what tests should be performed while she is in the ED?
Should a patient with major depressive disorder and anxiety who is currently on buspirone 5 mg three times daily be started on sertraline as the SSRI for comorbid alcohol use disorder, and what treatment plan is recommended?
What is the recommended dosing regimen for filgrastim (Neupogen) in an adult patient with HIV‑associated neutropenia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.